Glodiana - Sinanaj

Dr. Glodiana - Sinanaj

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2025 in infermieristica journal
Verified
Journal Article
Open access
PDF file
BSBrunilda Subashi
Brunilda Subashi
Fatjona KamberiFatjona Kamberi
Fatjona Kamberi
EKErlini Kokalla
Erlini Kokalla
RLRezarta Lalo
Rezarta Lalo
GSGlodiana - Sinanaj
Glodiana - Sinanaj
Introduction. Multimorbidity is an increasing global concern, particularly among older populations, affecting 55-98% of those aged ≥ 65 and above. This study aims to provide a comprehensive global overview of research on multimorbidity in older adults. It will assess the quantity and types of studies focused on the prevalence, patterns, determinants, risk factors, and consequences of multimorbidity, while also identifying key research gaps for future studies. Methods. This mapping review study was conducted using the PubMed, Scopus and Web of Science databases in December 2024. Only full-text papers published in English were included. The search terms included ‘aged’, ‘multimorbidity’, ‘multiple chronic conditions’, ‘prevalence’, ‘cost of illness’, ‘social determinants’, ‘risk factors’, and ‘Albania’. After filtering, all results were exported to Rayyan reference management software. Duplicates were removed, and the remaining papers were evaluated for suitability based on their titles and abstracts. Results. After the full text screening the final set for data extraction includes seven observational studies on multimorbidity in older adults. Europe has the highest number of studies, with four, followed by Asia with three studies. Despite this, Asia has a greater coverage of studies on multimorbidity in older populations. North and South America are represented by two studies from each. Six of included studies examine the prevalence of multimorbidity, with four exploring its patterns and consequences, and one investigating its determinants and its risk factors. Discussions. There are notable gaps in research on multimorbidity in older adults, particularly regarding its determinants, and risk factors. No studies on multimorbidity in older adults were found for Africa and Australia in the period 2019-2024.

5 September 2025 in Journal of Ageing and Longevity
Verified
Journal Article
Open access
PDF file
BSBrunilda Subashi
Brunilda Subashi
Fatjona KamberiFatjona Kamberi
Fatjona Kamberi
GSGlodiana - Sinanaj
Glodiana - Sinanaj
VPVasilika Prifti
Vasilika Prifti
EKErlini Kokalla
Erlini Kokalla
RLRezarta Lalo
Rezarta Lalo
The Older People’s Quality of Life Questionnaire (OPQOL-35) is a validated tool used to measure quality of life in the older people in many countries. The study describes the linguistic validation, cultural adaption, and pilot testing of the Albanian version of the OPQOL-35 (AL-OPQOL-35) in older adults, confirming its internal consistency and reliability. The process of linguistic validation, cross-cultural verification and adaptation of the AL-OPQOL-35 questionnaire went through four stages: forward translation, backward translation, patient testing, and proofreading. The AL-OPQOL-35 instrument obtained after forward–backward translation was tested on a sample of 40 elderly people with chronic diseases and multimorbidity. The sample consisted of 75% females and the age group 65–74 makes up the highest percentage with 72.5%. The sample consisted of 25% with one chronic disease, while 75% had two or more chronic diseases. After the evaluation by a panel of experts and pilot testing, the AL-OPQOL-35 was found to be clear and understandable for older adults with chronic conditions and multimorbidity, showing good reliability with a Cronbach’s alpha α = 0.848. It is recommended to use the AL-OPQOL-35 instrument in a larger population and evaluate its psychometric properties.